Allen R. Miller, PhD, MBA
Advertisement
Articles by Allen R. Miller, PhD, MBA
How can this combination of treatments help create positive change for individuals struggling with addiction?
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial
2
Experience With Xanomeline/Trospium in an Acute Inpatient Setting Treating Individuals With Schizophrenia
3
FDA Approves Tauklarify (MK-6240) For Tau Pathology Detection in Alzheimer Disease
4
New Ingrezza Data Shows Improved Quality of Life and Daily Functioning in Tardive Dyskinesia
5